ClinicalTrials.Veeva

Find clinical trials for Acute Myeloid Leukemia (AML) in Kansas City, KS

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Leukemia
Acute Myeloid Leukemia
Myeloid Leukemia
Myelodysplastic Syndromes
Preleukemia
Syndrome
Cancer

Acute Myeloid Leukemia (AML) trials near Kansas City, KS, USA:

A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation

The purpose of this study is to determine the clinical benefit of ASP2215 therapy in participants with FMS-like tyrosine kinase (FLT3) mutated acute...

Active, not recruiting
Leukemia, Acute Myeloid (AML)
Drug: LoDAC (Low Dose Cytarabine)
Drug: MEC (Mitoxantrone, Etoposide, Cytarabine)

Phase 3

Astellas
Astellas

Westwood, Kansas, United States and 125 other locations

allogeneic hematopoietic stem cell transplant (HCT), versus Conventional Care in patients with Active, Relapsed or Refractory Acute Myeloid...

Active, not recruiting
AML
Acute Myelogenous Leukemia
Drug: Conventional Care
Drug: Iomab-B

Phase 3

Actinium Pharmaceuticals
Actinium Pharmaceuticals

Westwood, Kansas, United States and 23 other locations

to venetoclax + azacitidine in adults recently diagnosed with AML who are unable to be treated with intensive chemotherapy.Participants will...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Drug: Venetoclax
Drug: Pevonedistat

Phase 2

Takeda
Takeda

Kansas City, Missouri, United States and 56 other locations

[GO]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse who...

Enrolling
Acute Myeloid Leukemia
Drug: Fludarabine
Drug: Cytarabine

Phase 3

LLS PedAL Initiative, LLC

Kansas City, Missouri, United States and 71 other locations

with partial hematologic recovery [CRh], than venetoclax plus decitabine alone (by historical comparison) in participants with untreated AML...

Enrolling
Acute Myeloid Leukemia (AML)
Drug: BP1001 plus decitabine
Drug: BP1001 in combination with Ventoclax plus decitabine

Phase 2

Bio-Path

Fairway, Kansas, United States and 8 other locations

This study enrolled 472 participants, aged 55 or older, with a diagnosis of de novo acute myeloid leukemia (AML) ...

Active, not recruiting
Leukemia, Myeloid, Acute
Drug: Placebo
Drug: Oral Azacitidine

Phase 3

Celgene
Celgene

Kansas City, Missouri, United States and 222 other locations

in combination with venetoclax for the treatment of newly diagnosed acute myeloid leukemia (AML) in adults who ar...

Active, not recruiting
Acute Myeloid Leukemia
Drug: Venetoclax
Drug: Decitabine and Cedazuridine (ASTX727)

Phase 1, Phase 2

Astex Pharmaceuticals
Astex Pharmaceuticals

Kansas City, Missouri, United States and 33 other locations

T cell therapy (VCAR33) in patients with relapsed or refractory Acute Myeloid Leukemia (AML) after human leukocyt...

Enrolling
Leukemia, Myeloid, Acute
Biological: VCAR33

Phase 1, Phase 2

Vor Biopharma

Fairway, Kansas, United States and 11 other locations

(mCRPC), higher risk myelodysplastic syndrome (HRMDS), acute myeloid leukemia (AML) and newly diagnosed intermed...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Drug: ASTX727
Drug: Dexamethasone

Phase 1, Phase 2

Karyopharm Therapeutics
Karyopharm Therapeutics

Kansas City, Missouri, United States and 45 other locations

2D level of APVO436 administered intravenously (IV) in patients with AML or MDS, andEvaluate the safety and tolerability of APVO436 at the R...

Enrolling
AML
MDS
Biological: APVO436

Phase 1

Aptevo Therapeutics

Westwood, Kansas, United States and 11 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems